# Official Journal C 266/29 O

| | ISSN 1725-2423 |
| --- | --- |
| Official Journal
  of the European Union | C 266 |
| | |
| English edition | Information and Notices | Volume 4729 October 2004 |

ISSN 1725-2423

Official Journal

of the European Union

C 266

English edition

Information and Notices

Volume 4729 October 2004

---

| Notice No | Contents | page |
| --- | --- | --- |
| | I   Information |
| | Commission |
| 2004/C 266/1 | Euro exchange rates | 1 |
| 2004/C 266/2 | Prior notification of a concentration (Case COMP/M.3606 — SIEMENS/BONUS ENERGY) — Candidate case for simplified procedure (
  1
  ) | 2 |
| 2004/C 266/3 | Communication from the Commission — Corresponding values of the thresholds of Directives 2994/17/EC and 2004/18/EC of the European Parliament and of the Council as amended by Commission Regulation (EC) No .../2004 (
  1
  ) | 3 |
| 2004/C 266/4 | Summary of Community decisions on marketing authorizations in respect of medicinal products from 15 September 2004 to 15 October 2004(Published pursuant to Article 12 or Article 34 of Council Regulation (EEC) No 2309/93) | 5 |
| 2004/C 266/5 | Prior notification of a concentration (Case COMP/M.3596 — THYSSENKRUPP/HDW) — Candidate case for simplified procedure (
  1
  ) | 8 |
| 2004/C 266/6 | Prior notification of a concentration (Case COMP/M.3579 — WPP/GREY) (
  1
  ) | 9 |
| 2004/C 266/7 | Prior notification of a concentration (Case COMP/M.3604 — PERMIRA/AHOLD IBERIA) — Candidate case for simplified procedure (
  1
  ) | 10 |

Notice No

Contents

page

I   Information

Commission

2004/C 266/1

Euro exchange rates

1

2004/C 266/2

Prior notification of a concentration (Case COMP/M.3606 — SIEMENS/BONUS ENERGY) — Candidate case for simplified procedure (
  1
  )

1

2

2004/C 266/3

Communication from the Commission — Corresponding values of the thresholds of Directives 2994/17/EC and 2004/18/EC of the European Parliament and of the Council as amended by Commission Regulation (EC) No .../2004 (
  1
  )

1

3

2004/C 266/4

Summary of Community decisions on marketing authorizations in respect of medicinal products from 15 September 2004 to 15 October 2004(Published pursuant to Article 12 or Article 34 of Council Regulation (EEC) No 2309/93)

(Published pursuant to Article 12 or Article 34 of Council Regulation (EEC) No 2309/93)

5

2004/C 266/5

Prior notification of a concentration (Case COMP/M.3596 — THYSSENKRUPP/HDW) — Candidate case for simplified procedure (
  1
  )

1

8

2004/C 266/6

Prior notification of a concentration (Case COMP/M.3579 — WPP/GREY) (
  1
  )

1

9

2004/C 266/7

Prior notification of a concentration (Case COMP/M.3604 — PERMIRA/AHOLD IBERIA) — Candidate case for simplified procedure (
  1
  )

1

10

---

| | III   Notices |
| --- | --- |
| | Commission |
| 2004/C 266/8 | AGIS work programme 2005 | 11 |

III   Notices

Commission

2004/C 266/8

AGIS work programme 2005

11

---

| | |
| --- | --- |
| | (1)   Text with EEA relevance |

---

(1)   Text with EEA relevance

1

| EN | |
| --- | --- |

EN

---

I Information

Commission

| 29.10.2004 | EN | Official Journal of the European Union | C 266/1 |
| --- | --- | --- | --- |

29.10.2004

EN

Official Journal of the European Union

C 266/1

---

Euro exchange rates (1)

28 October 2004

(2004/C 266/01)

1 euro
  =

| | Currency | Exchange rate |
| --- | --- | --- |
| USD | US dollar | 1,2711 |
| JPY | Japanese yen | 135,20 |
| DKK | Danish krone | 7,4342 |
| GBP | Pound sterling | 0,6957 |
| SEK | Swedish krona | 9,0426 |
| CHF | Swiss franc | 1,5316 |
| ISK | Iceland króna | 88,12 |
| NOK | Norwegian krone | 8,1935 |
| BGN | Bulgarian lev | 1,9558 |
| CYP | Cyprus pound | 0,5763 |
| CZK | Czech koruna | 31,617 |
| EEK | Estonian kroon | 15,6466 |
| HUF | Hungarian forint | 246,38 |
| LTL | Lithuanian litas | 3,4528 |
| LVL | Latvian lats | 0,6743 |
| MTL | Maltese lira | 0,4308 |
| PLN | Polish zloty | 4,3424 |
| ROL | Romanian leu | 40 925 |
| SIT | Slovenian tolar | 239,89 |
| SKK | Slovak koruna | 39,955 |
| TRL | Turkish lira | 1 874 700 |
| AUD | Australian dollar | 1,7127 |
| CAD | Canadian dollar | 1,5606 |
| HKD | Hong Kong dollar | 9,892 |
| NZD | New Zealand dollar | 1,8645 |
| SGD | Singapore dollar | 2,1151 |
| KRW | South Korean won | 1 433,17 |
| ZAR | South African rand | 7,8529 |

Currency

Exchange rate

USD

US dollar

1,2711

JPY

Japanese yen

135,20

DKK

Danish krone

7,4342

GBP

Pound sterling

0,6957

SEK

Swedish krona

9,0426

CHF

Swiss franc

1,5316

ISK

Iceland króna

88,12

NOK

Norwegian krone

8,1935

BGN

Bulgarian lev

1,9558

CYP

Cyprus pound

0,5763

CZK

Czech koruna

31,617

EEK

Estonian kroon

15,6466

HUF

Hungarian forint

246,38

LTL

Lithuanian litas

3,4528

LVL

Latvian lats

0,6743

MTL

Maltese lira

0,4308

PLN

Polish zloty

4,3424

ROL

Romanian leu

40 925

SIT

Slovenian tolar

239,89

SKK

Slovak koruna

39,955

TRL

Turkish lira

1 874 700

AUD

Australian dollar

1,7127

CAD

Canadian dollar

1,5606

HKD

Hong Kong dollar

9,892

NZD

New Zealand dollar

1,8645

SGD

Singapore dollar

2,1151

KRW

South Korean won

1 433,17

ZAR

South African rand

7,8529

---

(1)

Source: reference exchange rate published by the ECB.

---

| 29.10.2004 | EN | Official Journal of the European Union | C 266/2 |
| --- | --- | --- | --- |

29.10.2004

EN

Official Journal of the European Union

C 266/2

---

Prior notification of a concentration

(Case COMP/M.3606 — SIEMENS/BONUS ENERGY)

Candidate case for simplified procedure

(2004/C 266/02)

(Text with EEA relevance)

| 1. | On 22 October 2004, the Commission received a notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1) by which the undertaking Siemens Aktiengesellschaft (‘Siemens’, Germany) acquires within the meaning of Article 3(1)(b) of the Council Regulation control of the whole of the undertaking BONUS Energy A/S (‘Bonus’, Denmark), controlled by Danregn Vindkraft A/S (Denmark) by way of purchase of shares. |
| --- | --- |

1.

On 22 October 2004, the Commission received a notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1) by which the undertaking Siemens Aktiengesellschaft (‘Siemens’, Germany) acquires within the meaning of Article 3(1)(b) of the Council Regulation control of the whole of the undertaking BONUS Energy A/S (‘Bonus’, Denmark), controlled by Danregn Vindkraft A/S (Denmark) by way of purchase of shares.

| 2. | The business activities of the undertakings concerned are:






  — | for Siemens: global technology company active in the business areas Information Communication, Automation Control, Power, Transportation, Medical, Lighting, as well as Financing and Real Estate, |
| --- | --- | --- |

2.

The business activities of the undertakings concerned are:

—

for Siemens: global technology company active in the business areas Information Communication, Automation Control, Power, Transportation, Medical, Lighting, as well as Financing and Real Estate,

| — | for Bonus: manufacturer of wind turbines. |
| --- | --- |

—

for Bonus: manufacturer of wind turbines.

| 3. | On preliminary examination, the Commission finds that the notified transaction could fall within the scope of Regulation (EC) No 139/2004. However, the final decision on this point is reserved. Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under Council Regulation (EC) No 139/2004 (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice. |
| --- | --- |

3.

On preliminary examination, the Commission finds that the notified transaction could fall within the scope of Regulation (EC) No 139/2004. However, the final decision on this point is reserved. Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under Council Regulation (EC) No 139/2004 (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.

| 4. | The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.
  Observations must reach the Commission not later than 10 days following the date of this publication. Observations can be sent to the Commission by fax (No +32/2/2964301 or 2967244) or by post, under reference number COMP/M.3606 — Siemens/Bonus Energy, to the following address:





  European Commission |
| --- | --- |
| Directorate-General for Competition, |
| Merger Registry |
| J-70 |
| B-1049 Bruxelles/Brussel |

4.

The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.

Observations must reach the Commission not later than 10 days following the date of this publication. Observations can be sent to the Commission by fax (No +32/2/2964301 or 2967244) or by post, under reference number COMP/M.3606 — Siemens/Bonus Energy, to the following address:

European Commission

Directorate-General for Competition,

Merger Registry

J-70

B-1049 Bruxelles/Brussel

---

(1)  OJ L 24, 29.1.2004, p. 1.

(2)  Available on DG COMP website:

http://europa.eu.int/comm/competition/mergers/legislation/consultation/simplified_tru.pdf.

---

| 29.10.2004 | EN | Official Journal of the European Union | C 266/3 |
| --- | --- | --- | --- |

29.10.2004

EN

Official Journal of the European Union

C 266/3

---

COMMUNICATION FROM THE COMMISSION

Corresponding values of the thresholds of Directives 2994/17/EC and 2004/18/EC of the European Parliament and of the Council as amended by Commission Regulation (EC) No 1874/2004

(2004/C 266/03)

(Text with EEA relevance)

The corresponding values in the national currencies other than euros of the thresholds of Directives 2004/17/EC and 2004/18/EC, as amended by Commission Regulation (EC) No 1874/2004 (1), are the following:

| EUR 154 000 | Danish krone (DKK) | 1 144 511 |
| --- | --- | --- |
| Swedish krona (SEK) | 1 420 945 |
| Pound sterling (GBP) | 99 685 |
| Czech koruna (CZK) | 4 854 615 |
| Estonian kroon (EEK) | 2 409 576 |
| Cyprus pound (CYP) | 89 019 |
| Latvian lats (LVL) | 91 791 |
| Lithuanian litas (LTL) | 535 883 |
| Hungarian forint (HUF) | 38 074 374 |
| Maltese lira (MTL) | 63 665 |
| New Polish zloty (PLN) | 613 300 |
| Slovenian tolar (SIT) | 34 998 411 |
| Slovak koruna (SKK) | 6 535 456 |
| EUR 236 000 | Danish krone (DKK) | 1 753 926 |
| Swedish krona (SEK) | 2 177 551 |
| Pound sterling (GBP) | 152 765 |
| Czech koruna (CZK) | 7 439 540 |
| Estonian kroon (EEK) | 3 692 598 |
| Cyprus pound (CYP) | 136 419 |
| Latvian lats (LVL) | 140 666 |
| Lithuanian litas (LTL) | 821 223 |
| Hungarian forint (HUF) | 58 347 742 |
| Maltese lira (MTL) | 97 564 |
| New Polish zloty (PLN) | 939 862 |
| Slovenian tolar (SIT) | 53 633 929 |
| Slovak koruna (SKK) | 10 015 375 |
| EUR 5 923 000 | Danish krone (DKK) | 44 019 088 |
| Swedish krona (SEK) | 54 651 002 |
| Pound sterling (GBP) | 3 834 007 |
| Czech koruna (CZK) | 186 713 544 |
| Estonian kroon (EEK) | 92 674 812 |
| Cyprus pound (CYP) | 3 423 759 |
| Latvian lats (LVL) | 3 530 360 |
| Lithuanian litas (LTL) | 20 610 618 |
| Hungarian forint (HUF) | 1 464 379 973 |
| Maltese lira (MTL) | 2 448 614 |
| New Polish zloty (PLN) | 23 588 140 |
| Slovenian tolar (SIT) | 1 346 075 268 |
| Slovak koruna (SKK) | 251 360 438 |
| EUR 473 000 | Danish krone (DKK) | 3 515 284 |
| Swedish krona (SEK) | 4 364 330 |
| Pound sterling (GBP) | 306 177 |
| Czech koruna (CZK) | 14 910 604 |
| Estonian kroon (EEK) | 7 400 842 |
| Cyprus pound (CYP) | 273 415 |
| Latvian lats (LVL) | 281 928 |
| Lithuanian litas (LTL) | 1 645 926 |
| Hungarian forint (HUF) | 116 942 719 |
| Maltese lira (MTL) | 195 542 |
| New Polish zloty (PLN) | 1 883 706 |
| Slovenian tolar (SIT) | 107 495 121 |
| Slovak koruna (SKK) | 20 073 187 |

EUR 154 000

Danish krone (DKK)

1 144 511

Swedish krona (SEK)

1 420 945

Pound sterling (GBP)

99 685

Czech koruna (CZK)

4 854 615

Estonian kroon (EEK)

2 409 576

Cyprus pound (CYP)

89 019

Latvian lats (LVL)

91 791

Lithuanian litas (LTL)

535 883

Hungarian forint (HUF)

38 074 374

Maltese lira (MTL)

63 665

New Polish zloty (PLN)

613 300

Slovenian tolar (SIT)

34 998 411

Slovak koruna (SKK)

6 535 456

EUR 236 000

Danish krone (DKK)

1 753 926

Swedish krona (SEK)

2 177 551

Pound sterling (GBP)

152 765

Czech koruna (CZK)

7 439 540

Estonian kroon (EEK)

3 692 598

Cyprus pound (CYP)

136 419

Latvian lats (LVL)

140 666

Lithuanian litas (LTL)

821 223

Hungarian forint (HUF)

58 347 742

Maltese lira (MTL)

97 564

New Polish zloty (PLN)

939 862

Slovenian tolar (SIT)

53 633 929

Slovak koruna (SKK)

10 015 375

EUR 5 923 000

Danish krone (DKK)

44 019 088

Swedish krona (SEK)

54 651 002

Pound sterling (GBP)

3 834 007

Czech koruna (CZK)

186 713 544

Estonian kroon (EEK)

92 674 812

Cyprus pound (CYP)

3 423 759

Latvian lats (LVL)

3 530 360

Lithuanian litas (LTL)

20 610 618

Hungarian forint (HUF)

1 464 379 973

Maltese lira (MTL)

2 448 614

New Polish zloty (PLN)

23 588 140

Slovenian tolar (SIT)

1 346 075 268

Slovak koruna (SKK)

251 360 438

EUR 473 000

Danish krone (DKK)

3 515 284

Swedish krona (SEK)

4 364 330

Pound sterling (GBP)

306 177

Czech koruna (CZK)

14 910 604

Estonian kroon (EEK)

7 400 842

Cyprus pound (CYP)

273 415

Latvian lats (LVL)

281 928

Lithuanian litas (LTL)

1 645 926

Hungarian forint (HUF)

116 942 719

Maltese lira (MTL)

195 542

New Polish zloty (PLN)

1 883 706

Slovenian tolar (SIT)

107 495 121

Slovak koruna (SKK)

20 073 187

---

(1)  OJ L 326, 29.10.2004, p. 17.

---

| 29.10.2004 | EN | Official Journal of the European Union | C 266/5 |
| --- | --- | --- | --- |

29.10.2004

EN

Official Journal of the European Union

C 266/5

---

Summary of Community decisions on marketing authorizations in respect of medicinal products from 15 September 2004 to 15 October 2004

(Published pursuant to Article 12 or Article 34 of Council Regulation (EEC) No 2309/93 (1))

(2004/C 266/04)

Issuing of a marketing authorisation (Article 12 of Council Regulation (EEC) No 2309/93): Accepted

| Date of the decision | Name of the medicinal product | Holder of the marketing authorisation | Number of the entry in the Community Register | Date of notification |
| --- | --- | --- | --- | --- |
| 20.9.2004 | Angiox | The Medicines Company UK Ltd, Suite B, Park House, 11 Milton Park, Abingdon, Oxfordshire OX14 4RS, United Kingdom | EU/1/04/289/001 | 22.9.2004 |
| 20.9.2004 | Alimta | Eli Lilly Nederland BV, Grootslag 1-5, 3991 RA Houten, Nederland | EU/1/04/290/001 | 22.9.2004 |
| 20.9.2004 | Raptiva | Serono Europe Limited, 56, Marsh Wall, London E14 9TP, United Kingdom | EU/1/04/291/001-002 | 22.9.2004 |
| 21. 9.2004 | Protelos | Les Laboratoires Servier, 22, rue Garnier, F-92200 Neuilly-sur-Seine | EU/1/04/288/001-006 | 23.9.2004 |
| 21. 9.2004 | Osseor | Les Laboratoires Servier, 22, rue Garnier, F-92200 Neuilly-sur-Seine | EU/1/04/287/001-006 | 23.9.2004 |
| 27. 9.2004 | Apidra | Aventis Pharma Deutschland GmbH, Brueningstrasse 50, D-65926 Frankfurt am Main, | EU/1/04/285/001-020 | 29. 9.2004 |
| 13.10.2004 | Wilzin | Orphan Europe SARL, Immeuble ‘Le Guillaumet’ F-92046 Paris-La-Défense | EU/1/04/286/001-002 | 18.10.2004 |

Date of the decision

Name of the medicinal product

Holder of the marketing authorisation

Number of the entry in the Community Register

Date of notification

20.9.2004

Angiox

The Medicines Company UK Ltd, Suite B, Park House, 11 Milton Park, Abingdon, Oxfordshire OX14 4RS, United Kingdom

EU/1/04/289/001

22.9.2004

20.9.2004

Alimta

Eli Lilly Nederland BV, Grootslag 1-5, 3991 RA Houten, Nederland

EU/1/04/290/001

22.9.2004

20.9.2004

Raptiva

Serono Europe Limited, 56, Marsh Wall, London E14 9TP, United Kingdom

EU/1/04/291/001-002

22.9.2004

21. 9.2004

Protelos

Les Laboratoires Servier, 22, rue Garnier, F-92200 Neuilly-sur-Seine

EU/1/04/288/001-006

23.9.2004

21. 9.2004

Osseor

Les Laboratoires Servier, 22, rue Garnier, F-92200 Neuilly-sur-Seine

EU/1/04/287/001-006

23.9.2004

27. 9.2004

Apidra

Aventis Pharma Deutschland GmbH, Brueningstrasse 50, D-65926 Frankfurt am Main,

EU/1/04/285/001-020

29. 9.2004

13.10.2004

Wilzin

Orphan Europe SARL, Immeuble ‘Le Guillaumet’ F-92046 Paris-La-Défense

EU/1/04/286/001-002

18.10.2004

Modification of a marketing authorisation (Article 12 of Council Regulation (EEC) No 2309/93) Accepted

| Date of the decision | Name of the medicinal product | Holder of the marketing authorisation | Number of the entry in the Community Register | Date of notification |
| --- | --- | --- | --- | --- |
| 20.9.2004 | Remicade | Centocor BV, Einsteinweg 101, 2333 CB Leiden, Nederland | EU/1/99/116/001-003 | 22.9.2004 |
| 20.9.2004 | Azomyr | Schering Plough Europe, Rue de Stalle, 73, B-1180 Brussels | EU/1/00/157/014-021 | 22.9.2004 |
| 20.9.2004 | Aerius | Schering Plough Europe, Rue de Stalle, 73, B-1180 Brussels | EU/1/00/160/014-021 | 22.9.2004 |
| 20.9.2004 | Neoclarityn | Schering Plough Europe, Rue de Stalle, 73, B-1180 Brussels, | EU/1/00/161/014-021 | 22.9.2004 |
| 20.9.2004 | Lantus | Aventis Pharma Deutschland GmbH, D-65926 Frankfurt am Main, | EU/1/00/134/008-011
  EU/1/00/134/018-021 | 22.9.2004 |
| 20.9.2004 | Velcade | Millennium Pharmaceuticals, Ltd, Building 3, Chiswick Park, 566 Chiswick High Road, Chiswick, London, W4 5YA United Kingdom | EU/1/04/274/001 | 22.9.2004 |
| 20.9.2004 | Velcade | Janssen-Cilag International NV, Turnhoutsewe 30, B–2340 Beerse | EU/1/04/274/001 | 23.9.2004 |
| 20.9.2004 | Ovitrelle | Serono Europe Limited, 56, Marsh Wall, London E14 9TP, United Kingdom | EU/1/00/165/001-007 | 22.9.2004 |
| 21.9.2004 | Carbaglu | Orphan Europe, Immeuble ‘Le Guillaumet’, F-92046 Paris-La-Défense | EU/1/02/246/001-002 | 23.9.2004 |
| 21.9.2004 | KOGENATE Bayer | Bayer AG, D-51368 Leverkusen, Deutschland | EU/1/00/143/004-006 | 23.9.2004 |
| 23.9.2004 | Remicade | Centocor B.V., Einsteinweg 101, 2333 CB Leiden, Nederland | EU/1/99/116/001-003 | 27.9.2004 |
| 24.9.2004 | Insuman | Aventis Pharma Deutschland GmbH, Brueningstrasse 50, D-65926 Frankfurt am Main, | EU/1/97/030/065-084 | 29.9.2004 |
| 24.9.2004 | InductOs | Wyeth Europa Ltd., Huntercombe Lane South, Taplow, Maidenhead, Berkshire, SL6 0PH, United Kingdom | EU/1/02/226/001 | 28.9.2004 |
| 24.9.2004 | Enbrel | Wyeth Europa Limited, Huntercombe Lane South, Taplow, Maidenhead, Berkshire, SL6 0PH, United Kingdom | EU/1/99/126/001-003 | 28.9.2004 |
| 27.9.2004 | SonoVue | Bracco International BV, Strawinskylaan 3051, 1077ZX Amsterdam, Nederland | EU/1/01/177/001-002 | 29.9.2004 |
| 27.9.2004 | Ceprotin | Baxter AG, Industriesstrasse 67, 1220 Vienna, Österreich | EU/1/01/190/001-002 | 29.9.2004 |
| 27.9.2004 | Avonex | Biogen Idec France, ‘Le Capitole’ 55, avenue des Champs Pierreux, F-92012 Nanterre Cedex | EU/1/97/033/001-003 | 30. 9.2004 |
| 13.10.2004 | Revasc | Canyon Pharmaceuticals Ltd, 20-22 Bedford Row - WC1R 4JS London - United Kingdom | EU/1/97/043/001-002 | 19.10.2004 |
| Aventis Pharma SA, 20 Avenue Raymond Aron, Antony Cedex F-92165 | 18.10.2004 |
| 13.10.2004 | Arava | Aventis Pharma Deutschland GmbH, D-65926 Frankfurt am Main | EU/1/99/118/001-010 | 18.10.2004 |
| 13.10.2004 | Vaniqa | Shire Pharmaceutical Contracts Ltd, Hampshire International Business Park, Chineham, Basingstoke, Hampshire RG24 8EP, United Kingdom | EU/1/01/173/001-003 | 18.10.2004 |
| 13.10.2004 | NovoRapid | Novo Nordisk A/S, Novo Allé, DK-2880 Bagsvaerd | EU/1/99/119/001-014 | 18.10.2004 |
| 13.10.2004 | Levviax | Aventis Pharma SA, 20 Avenue Raymond Aron, F-92160 Antony | EU/1/01/192/001-005 | 19.10.2004 |
| 15.10.2004 | Ketek | Aventis Pharma SA, 20 Avenue Raymond Aron, F-92160 Antony | EU/1/01/191/001-005 | 19.10.2004 |
| 15.10.2004 | Viramune | Boehringer Ingelheim International GmbH, Binger Strasse, 173 D-55216 Ingelheim am Rhein, Deutschland | EU/1/97/055/001-002 | 19.10.2004 |
| 15.10.2004 | Fuzeon | Roche Registration Limited, 40 Broadwater Road, Welwyn Garden City, Hertfordshire AL7 3AY | EU/1/03/252/001-003 | 20.10.2004 |
| 15.10.2004 | NovoRapid | Novo Nordisk A/S, Novo Allé, DK-2880 Bagsvaerd | EU/1/99/119/001
  EU/1/99/119/003
  EU/1/99/119/005-014 | 19.10.2004 |

Date of the decision

Name of the medicinal product

Holder of the marketing authorisation

Number of the entry in the Community Register

Date of notification

20.9.2004

Remicade

Centocor BV, Einsteinweg 101, 2333 CB Leiden, Nederland

EU/1/99/116/001-003

22.9.2004

20.9.2004

Azomyr

Schering Plough Europe, Rue de Stalle, 73, B-1180 Brussels

EU/1/00/157/014-021

22.9.2004

20.9.2004

Aerius

Schering Plough Europe, Rue de Stalle, 73, B-1180 Brussels

EU/1/00/160/014-021

22.9.2004

20.9.2004

Neoclarityn

Schering Plough Europe, Rue de Stalle, 73, B-1180 Brussels,

EU/1/00/161/014-021

22.9.2004

20.9.2004

Lantus

Aventis Pharma Deutschland GmbH, D-65926 Frankfurt am Main,

EU/1/00/134/008-011

EU/1/00/134/018-021

22.9.2004

20.9.2004

Velcade

Millennium Pharmaceuticals, Ltd, Building 3, Chiswick Park, 566 Chiswick High Road, Chiswick, London, W4 5YA United Kingdom

EU/1/04/274/001

22.9.2004

20.9.2004

Velcade

Janssen-Cilag International NV, Turnhoutsewe 30, B–2340 Beerse

EU/1/04/274/001

23.9.2004

20.9.2004

Ovitrelle

Serono Europe Limited, 56, Marsh Wall, London E14 9TP, United Kingdom

EU/1/00/165/001-007

22.9.2004

21.9.2004

Carbaglu

Orphan Europe, Immeuble ‘Le Guillaumet’, F-92046 Paris-La-Défense

EU/1/02/246/001-002

23.9.2004

21.9.2004

KOGENATE Bayer

Bayer AG, D-51368 Leverkusen, Deutschland

EU/1/00/143/004-006

23.9.2004

23.9.2004

Remicade

Centocor B.V., Einsteinweg 101, 2333 CB Leiden, Nederland

EU/1/99/116/001-003

27.9.2004

24.9.2004

Insuman

Aventis Pharma Deutschland GmbH, Brueningstrasse 50, D-65926 Frankfurt am Main,

EU/1/97/030/065-084

29.9.2004

24.9.2004

InductOs

Wyeth Europa Ltd., Huntercombe Lane South, Taplow, Maidenhead, Berkshire, SL6 0PH, United Kingdom

EU/1/02/226/001

28.9.2004

24.9.2004

Enbrel

Wyeth Europa Limited, Huntercombe Lane South, Taplow, Maidenhead, Berkshire, SL6 0PH, United Kingdom

EU/1/99/126/001-003

28.9.2004

27.9.2004

SonoVue

Bracco International BV, Strawinskylaan 3051, 1077ZX Amsterdam, Nederland

EU/1/01/177/001-002

29.9.2004

27.9.2004

Ceprotin

Baxter AG, Industriesstrasse 67, 1220 Vienna, Österreich

EU/1/01/190/001-002

29.9.2004

27.9.2004

Avonex

Biogen Idec France, ‘Le Capitole’ 55, avenue des Champs Pierreux, F-92012 Nanterre Cedex

EU/1/97/033/001-003

30. 9.2004

13.10.2004

Revasc

Canyon Pharmaceuticals Ltd, 20-22 Bedford Row - WC1R 4JS London - United Kingdom

EU/1/97/043/001-002

19.10.2004

Aventis Pharma SA, 20 Avenue Raymond Aron, Antony Cedex F-92165

18.10.2004

13.10.2004

Arava

Aventis Pharma Deutschland GmbH, D-65926 Frankfurt am Main

EU/1/99/118/001-010

18.10.2004

13.10.2004

Vaniqa

Shire Pharmaceutical Contracts Ltd, Hampshire International Business Park, Chineham, Basingstoke, Hampshire RG24 8EP, United Kingdom

EU/1/01/173/001-003

18.10.2004

13.10.2004

NovoRapid

Novo Nordisk A/S, Novo Allé, DK-2880 Bagsvaerd

EU/1/99/119/001-014

18.10.2004

13.10.2004

Levviax

Aventis Pharma SA, 20 Avenue Raymond Aron, F-92160 Antony

EU/1/01/192/001-005

19.10.2004

15.10.2004

Ketek

Aventis Pharma SA, 20 Avenue Raymond Aron, F-92160 Antony

EU/1/01/191/001-005

19.10.2004

15.10.2004

Viramune

Boehringer Ingelheim International GmbH, Binger Strasse, 173 D-55216 Ingelheim am Rhein, Deutschland

EU/1/97/055/001-002

19.10.2004

15.10.2004

Fuzeon

Roche Registration Limited, 40 Broadwater Road, Welwyn Garden City, Hertfordshire AL7 3AY

EU/1/03/252/001-003

20.10.2004

15.10.2004

NovoRapid

Novo Nordisk A/S, Novo Allé, DK-2880 Bagsvaerd

EU/1/99/119/001

EU/1/99/119/003

EU/1/99/119/005-014

19.10.2004

Withdrawal of a marketing authorisation (Article 12 of Council Regulation (EEC) No 2309/93)

| Date of the decision | Name of the medicinal product | Holder of the marketing authorisation | Number of the entry in the Community Register | Date of notification |
| --- | --- | --- | --- | --- |
| 28.9.2004 | Ixense | Takeda Europe R&D Centre Ltd, Savanah House, 11/12 Charles II Street, London SW1Y 4QU, United Kingdom | EU/1/01/181/001-007 | 30.9.2004 |

Date of the decision

Name of the medicinal product

Holder of the marketing authorisation

Number of the entry in the Community Register

Date of notification

28.9.2004

Ixense

Takeda Europe R&D Centre Ltd, Savanah House, 11/12 Charles II Street, London SW1Y 4QU, United Kingdom

EU/1/01/181/001-007

30.9.2004

---

(1)   OJ L 214, 24.8.1993, p. 1.

---

| 29.10.2004 | EN | Official Journal of the European Union | C 266/8 |
| --- | --- | --- | --- |

29.10.2004

EN

Official Journal of the European Union

C 266/8

---

Prior notification of a concentration

(Case COMP/M.3596 — THYSSENKRUPP/HDW)

Candidate case for simplified procedure

(2004/C 266/05)

(Text with EEA relevance)

| 1. | On 19 October 2004, the Commission received a notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1) by which the undertaking ThyssenKrupp AG (‘ThyssenKrupp’, Germany) acquires within the meaning of Article 3(1)(b) of the Council Regulation control of the whole of the undertaking Howaldtswerke-Deutsche Werft AG (‘HDW’), controlled by One Equity Partners LLC (‘OEP’, USA), itself belonging to the J.P. Morgan Chase Corporation, by way of purchase of shares. By invoking Article 296(1)b of the EC Treaty, the German ministry for economic affairs has ordered ThyssenKrupp not to notify the military part of this transaction to the European Commission. |
| --- | --- |

1.

On 19 October 2004, the Commission received a notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1) by which the undertaking ThyssenKrupp AG (‘ThyssenKrupp’, Germany) acquires within the meaning of Article 3(1)(b) of the Council Regulation control of the whole of the undertaking Howaldtswerke-Deutsche Werft AG (‘HDW’), controlled by One Equity Partners LLC (‘OEP’, USA), itself belonging to the J.P. Morgan Chase Corporation, by way of purchase of shares. By invoking Article 296(1)b of the EC Treaty, the German ministry for economic affairs has ordered ThyssenKrupp not to notify the military part of this transaction to the European Commission.

| 2. | The business activities of the undertakings concerned are:






  — | for ThyssenKrupp: active in numerous industries including steel, mechanical engineering, plant construction, elevators, plastic products and car parts. Its Blohm& Voss and Nordseewerke Emden shipyards are active in design, supply and repair of civil and military vessels, |
| --- | --- | --- |

2.

The business activities of the undertakings concerned are:

—

for ThyssenKrupp: active in numerous industries including steel, mechanical engineering, plant construction, elevators, plastic products and car parts. Its Blohm& Voss and Nordseewerke Emden shipyards are active in design, supply and repair of civil and military vessels,

| — | for HDW: civil shipbuilding (passenger- and container ships, yachts), military shipbuilding (submarines and naval surface vessels) and ship repair services through shipyards in Germany, Sweden (Kockums ) and Greece (Hellenic Shipyard), |
| --- | --- |

—

for HDW: civil shipbuilding (passenger- and container ships, yachts), military shipbuilding (submarines and naval surface vessels) and ship repair services through shipyards in Germany, Sweden (Kockums ) and Greece (Hellenic Shipyard),

| — | for OEP: financial investments in various industries. |
| --- | --- |

—

for OEP: financial investments in various industries.

| 3. | On preliminary examination, the Commission finds that the notified transaction could fall within the scope of Regulation (EC) No 139/2004. However, the final decision on this point is reserved. Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under Council Regulation (EC) No 139/2004 (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice. |
| --- | --- |

3.

On preliminary examination, the Commission finds that the notified transaction could fall within the scope of Regulation (EC) No 139/2004. However, the final decision on this point is reserved. Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under Council Regulation (EC) No 139/2004 (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.

| 4. | The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.
  Observations must reach the Commission not later than 10 days following the date of this publication. Observations can be sent to the Commission by fax (No +32/2/2964301 or 2967244) or by post, under reference number Case COMP/M.3596 — ThyssenKrupp/HDW, to the following address:





  European Commission |
| --- | --- |
| Directorate-General for Competition, |
| Merger Registry |
| J-70 |
| B-1049 Bruxelles/Brussel |

4.

The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.

Observations must reach the Commission not later than 10 days following the date of this publication. Observations can be sent to the Commission by fax (No +32/2/2964301 or 2967244) or by post, under reference number Case COMP/M.3596 — ThyssenKrupp/HDW, to the following address:

European Commission

Directorate-General for Competition,

Merger Registry

J-70

B-1049 Bruxelles/Brussel

---

(1)  OJ L 24, 29.1.2004, p. 1.

(2)  Available on DG COMP website:

http://europa.eu.int/comm/competition/mergers/legislation/consultation/simplified_tru.pdf.

---

| 29.10.2004 | EN | Official Journal of the European Union | C 266/9 |
| --- | --- | --- | --- |

29.10.2004

EN

Official Journal of the European Union

C 266/9

---

Prior notification of a concentration

(Case COMP/M.3579 — WPP/GREY)

(2004/C 266/06)

(Text with EEA relevance)

| 1. | On 20 October 2004, the Commission received a notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1) by which the undertaking WPP Group plc (‘WPP’, UK) acquires within the meaning of Article 3(1)(b) of the Council Regulation control of the whole of the undertaking Grey Global Group Inc. (‘Grey’, USA) by way of purchase of shares. |
| --- | --- |

1.

On 20 October 2004, the Commission received a notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1) by which the undertaking WPP Group plc (‘WPP’, UK) acquires within the meaning of Article 3(1)(b) of the Council Regulation control of the whole of the undertaking Grey Global Group Inc. (‘Grey’, USA) by way of purchase of shares.

| 2. | The business activities of the undertakings concerned are:






  — | for WPP: advertising and marketing services, |
| --- | --- | --- |

2.

The business activities of the undertakings concerned are:

—

for WPP: advertising and marketing services,

| — | for Grey: advertising and marketing services. |
| --- | --- |

—

for Grey: advertising and marketing services.

| 3. | On preliminary examination, the Commission finds that the notified transaction could fall within the scope of Regulation (EC) No 139/2004. However, the final decision on this point is reserved. |
| --- | --- |

3.

On preliminary examination, the Commission finds that the notified transaction could fall within the scope of Regulation (EC) No 139/2004. However, the final decision on this point is reserved.

| 4. | The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.
  Observations must reach the Commission not later than 10 days following the date of this publication. Observations can be sent to the Commission by fax (No +32/2/2964301 or 2967244) or by post, under reference number COMP/M.3579 — WPP/Grey, to the following address:





  European Commission |
| --- | --- |
| Directorate-General for Competition, |
| Merger Registry |
| J-70 |
| B-1049 Bruxelles/Brussel |

4.

The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.

Observations must reach the Commission not later than 10 days following the date of this publication. Observations can be sent to the Commission by fax (No +32/2/2964301 or 2967244) or by post, under reference number COMP/M.3579 — WPP/Grey, to the following address:

European Commission

Directorate-General for Competition,

Merger Registry

J-70

B-1049 Bruxelles/Brussel

---

(1)  OJ L 24, 29.1.2004, p. 1.

---

| 29.10.2004 | EN | Official Journal of the European Union | C 266/10 |
| --- | --- | --- | --- |

29.10.2004

EN

Official Journal of the European Union

C 266/10

---

Prior notification of a concentration

(Case COMP/M.3604 — PERMIRA/AHOLD IBERIA)

Candidate case for simplified procedure

(2004/C 266/07)

(Text with EEA relevance)

| 1. | On 22 October 2004, the Commission received a notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1) by which the undertaking CMA, S.à.r.l. (Luxembourg) ultimately controlled by Permira Holdings Ltd (‘PHL’, Guernsey), acquires within the meaning of Article 3(1)(b) of the Council Regulation control of the whole of the undertaking Ahold Iberia B.V. (‘Ahold Iberia’, The Netherlands) by way of purchase of shares. |
| --- | --- |

1.

On 22 October 2004, the Commission received a notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1) by which the undertaking CMA, S.à.r.l. (Luxembourg) ultimately controlled by Permira Holdings Ltd (‘PHL’, Guernsey), acquires within the meaning of Article 3(1)(b) of the Council Regulation control of the whole of the undertaking Ahold Iberia B.V. (‘Ahold Iberia’, The Netherlands) by way of purchase of shares.

| 2. | The business activities of the undertakings concerned are:






  — | for undertaking PHL: private equity fund, |
| --- | --- | --- |

2.

The business activities of the undertakings concerned are:

—

for undertaking PHL: private equity fund,

| — | for undertaking Ahold Iberia: through Ahold Supermercados, active in the procurement, wholesale and retail of daily consumer goods and related services in Spain. |
| --- | --- |

—

for undertaking Ahold Iberia: through Ahold Supermercados, active in the procurement, wholesale and retail of daily consumer goods and related services in Spain.

| 3. | On preliminary examination, the Commission finds that the notified transaction could fall within the scope of Regulation (EC) No 139/2004. However, the final decision on this point is reserved. Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under Council Regulation (EC) No 139/2004 (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice. |
| --- | --- |

3.

On preliminary examination, the Commission finds that the notified transaction could fall within the scope of Regulation (EC) No 139/2004. However, the final decision on this point is reserved. Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under Council Regulation (EC) No 139/2004 (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.

| 4. | The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.
  Observations must reach the Commission not later than 10 days following the date of this publication. Observations can be sent to the Commission by fax (No +32 2 2964301 or 2967244) or by post, under reference number COMP/M.3604 — Permira/Ahold Iberia, to the following address:





  European Commission |
| --- | --- |
| Directorate-General for Competition, |
| Merger Registry |
| J-70 |
| B-1049 Bruxelles/Brussel |

4.

The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.

Observations must reach the Commission not later than 10 days following the date of this publication. Observations can be sent to the Commission by fax (No +32 2 2964301 or 2967244) or by post, under reference number COMP/M.3604 — Permira/Ahold Iberia, to the following address:

European Commission

Directorate-General for Competition,

Merger Registry

J-70

B-1049 Bruxelles/Brussel

---

(1)  OJ L 24, 29.1.2004, p. 1.

(2)  Available on DG COMP website:

http://europa.eu.int/comm/competition/mergers/legislation/consultation/simplified_tru.pdf.

---

III Notices

Commission

| 29.10.2004 | EN | Official Journal of the European Union | C 266/11 |
| --- | --- | --- | --- |

29.10.2004

EN

Official Journal of the European Union

C 266/11

---

AGIS work programme 2005

(2004/C 266/08)

The complete 2005 AGIS work programme and call for proposals is published on the JHA website at: http://europa.eu.int/comm/justice_home/funding/agis/funding_agis_en.htm.

Deadline for presentation of proposals: 15 December 2004.

---